News coverage about Dynatronics (NASDAQ:DYNT) has trended somewhat positive on Wednesday, Accern reports. The research group identifies negative and positive press coverage by analyzing more than twenty million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Dynatronics earned a news impact score of 0.17 on Accern’s scale. Accern also gave media headlines about the medical equipment provider an impact score of 47.2017288092656 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.
These are some of the news stories that may have effected Accern Sentiment’s scoring:
- Dynatronics (DYNT) Upgraded to Buy at Zacks Investment Research (americanbankingnews.com)
- Head-To-Head Contrast: Luminex (LMNX) vs. Dynatronics (DYNT) (americanbankingnews.com)
- Brian Larkin Acquires 40,000 Shares of Dynatronics Co. (DYNT) Stock (americanbankingnews.com)
- Dynatronics Co. (DYNT) Major Shareholder Ventures 1 Lp Provco Buys 300,000 Shares (americanbankingnews.com)
- Should You Be Concerned About Dynatronics Corporation’s (DYNT) -24.3% Earnings Decline? (finance.yahoo.com)
Separately, Zacks Investment Research raised shares of Dynatronics from a “hold” rating to a “buy” rating and set a $3.00 price target for the company in a report on Tuesday.
Dynatronics (NASDAQ:DYNT) last issued its quarterly earnings data on Tuesday, November 14th. The medical equipment provider reported $0.00 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.08) by $0.08. The business had revenue of $12.80 million during the quarter. Dynatronics had a negative net margin of 3.42% and a negative return on equity of 45.78%. sell-side analysts expect that Dynatronics will post -0.09 earnings per share for the current fiscal year.
In related news, major shareholder Ventures 1 Lp Provco acquired 300,000 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The stock was acquired at an average price of $2.50 per share, with a total value of $750,000.00. Following the purchase, the insider now directly owns 586,944 shares in the company, valued at $1,467,360. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Brian Larkin acquired 40,000 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The stock was bought at an average cost of $2.50 per share, with a total value of $100,000.00. Following the purchase, the director now owns 80,276 shares in the company, valued at $200,690. The disclosure for this purchase can be found here. 51.80% of the stock is owned by corporate insiders.
Dynatronics Company Profile
Dynatronics Corporation is a manufacturer and distributor of physical medicine products. The Company’s products include a line of medical equipment for physical medicine applications, including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. Its products are used by physical therapists, chiropractors, sports medicine practitioners, podiatrists, physicians and other physical medicine professionals.
What are top analysts saying about Dynatronics Co.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Dynatronics Co. and related companies.